Fischer Medical Ventures Releases 33rd Annual Report

Fischer Medical Ventures Limited has published its 33rd Annual Report for the financial year 2025-2026. The report details the company's 'Next Phase of Innovation-Led Growth,' highlighting achievements such as crossing ₹100 crore in consolidated revenue and gaining trust from radiologists for its MRI platforms. The company, headquartered in Vizag, operates in magnetic resonance imaging (MRI), computed tomography (CT), digital radiography, AI-powered preventive healthcare, advanced wound care, and digital health technologies. The report is available on their website and outlines strategic initiatives for scaling their imaging portfolio, accelerating technology pipelines, expanding market reach, and strengthening manufacturing capabilities. Forward-looking statements are included with a disclaimer regarding inherent risks and uncertainties.